Xencor | Ativo Circulante



Current Assets Alterar Data
AbbVie USD 25.58B 2.2B 2024-12
Alnylam Pharmaceuticals USD 3.27B 27.03M 2025-03
Amgen USD 26.93B 2.1B 2025-03
Arrowhead Research USD 1.14B 564.68M 2025-03
AstraZeneca USD 26.14B 312M 2025-03
Biogen USD 7.63B 169.2M 2025-03
Bristol-Myers Squibb USD 30.78B 1B 2025-03
Cytokinetics USD 956.05M 151.89M 2025-03
GlaxoSmithKline GBP 18.08B 1.09B 2025-03
J&J USD 71.55B 15.66B 2025-03
MacroGenics USD 217.49M 4.71M 2024-12
Merck USD 35.5B 3.28B 2025-03
Novartis USD 29.7B 1.56B 2024-12
Pfizer USD 45.86B 4.5B 2025-03
Regeneron Pharmaceuticals USD 17.57B 9.64B 2025-03
Roche Holding CHF 40.04B 6.41B 2024-12
Xencor USD 521.27M 56.33M 2025-03



Xencor Ativo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - May 2025.